menu search

Vyant bio says it is ‘well-positioned' to discover novel therapeutics to treat neurological diseases

Vyant Bio (NASDAQ:VYNT) Inc CEO Jay Roberts told shareholders that after its merger the company is “well-positioned” to pursue the discovery of no...

March 1, 2022, 12:20 pm

Ionis to present at the cowen annual health care conference

CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a pane...

March 1, 2022, 7:05 am

Ionis to present at the cowen annual health care conference

CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a pane...

March 1, 2022, 7:05 am

Ionis to present at the cowen annual health care conference

CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in a pane...

March 1, 2022, 7:05 am

Harmony biosciences announces date of fourth quarter and full year 2021 financial results

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated...

February 14, 2022, 8:05 am

Harmony biosciences announces date of fourth quarter and full year 2021 financial results

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated...

February 14, 2022, 8:05 am

Harmony biosciences announces date of fourth quarter and full year 2021 financial results

PLYMOUTH MEETING, Pa., Feb. 14, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated...

February 14, 2022, 8:05 am

Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have published a paper about its candidate KRM-II-81, ...

January 25, 2022, 8:43 am

Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have published a paper about its candidate KRM-II-81, ...

January 25, 2022, 8:43 am

Respirerx pharmaceuticals notes publication of paper on gabakine krm-ii-81, which it is advancing for epilepsy and pain

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc revealed that scientists associated with the company have published a paper about its candidate KRM-II-81, ...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treat...

January 25, 2022, 8:43 am

Cortexyme and the gingipain hypothesis of alzheimer's disease

Cortexyme has a unique hypothesis- that Alzheimer's disease (AD) is caused by a neurological infection ...

October 11, 2021, 8:30 am

Cortexyme and the gingipain hypothesis of alzheimer's disease

Cortexyme has a unique hypothesis- that Alzheimer's disease (AD) is caused by a neurological infection ...

October 11, 2021, 8:30 am

Cortexyme and the gingipain hypothesis of alzheimer's disease

Cortexyme has a unique hypothesis- that Alzheimer's disease (AD) is caused by a neurological infection ...

October 11, 2021, 8:30 am

Pasithea therapeutics corp. and evotec se enter into drug development agreement

-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...

October 11, 2021, 8:20 am

Pasithea therapeutics corp. and evotec se enter into drug development agreement

-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...

October 11, 2021, 8:20 am

Pasithea therapeutics corp. and evotec se enter into drug development agreement

-- Company contracts leading global drug development company to advance initial drug candidate -- Miami Beach, FL / October 11, 2021 -- Pasithea Thera...

October 11, 2021, 8:20 am

Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference

ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...

October 8, 2021, 9:15 am


Search within

Pages Search Results: